Avidity Partners Management as of June 30, 2021
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 112 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.2 | $192M | 950k | 201.63 | |
| Abbvie (ABBV) | 4.5 | $167M | 1.5M | 112.64 | |
| Arvinas Ord (ARVN) | 3.9 | $143M | 1.9M | 77.00 | |
| Eli Lilly & Co. (LLY) | 3.5 | $130M | 566k | 229.52 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 3.3 | $124M | 3.0M | 41.73 | |
| Mirati Therapeutics | 3.3 | $122M | 753k | 161.53 | |
| Zentalis Pharmaceuticals (ZNTL) | 3.1 | $115M | 2.2M | 53.20 | |
| Avantor (AVTR) | 3.1 | $113M | 3.2M | 35.51 | |
| Seagen | 2.7 | $101M | 640k | 157.88 | |
| Biohaven Pharmaceutical Holding | 2.3 | $86M | 883k | 97.08 | |
| Hologic (HOLX) | 2.2 | $81M | 1.2M | 66.72 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $79M | 4.6M | 17.17 | |
| Essa Pharma Com New (EPIX) | 2.1 | $79M | 2.8M | 28.57 | |
| EXACT Sciences Corporation (EXAS) | 2.0 | $73M | 590k | 124.31 | |
| Medtronic SHS (MDT) | 1.8 | $66M | 535k | 124.13 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $66M | 681k | 97.32 | |
| Nuvation Bio Com Cl A (NUVB) | 1.8 | $65M | 7.0M | 9.31 | |
| Arena Pharmaceuticals Com New | 1.7 | $64M | 943k | 68.20 | |
| Biogen Idec (BIIB) | 1.7 | $64M | 184k | 346.27 | |
| Neogenomics Com New (NEO) | 1.7 | $62M | 1.4M | 45.17 | |
| Intellia Therapeutics (NTLA) | 1.7 | $62M | 380k | 161.91 | |
| I Mab Sponsored Ads (IMAB) | 1.7 | $61M | 729k | 83.95 | |
| Catalent | 1.6 | $58M | 540k | 108.12 | |
| Shattuck Labs (STTK) | 1.5 | $56M | 1.9M | 28.99 | |
| Centene Corporation (CNC) | 1.5 | $55M | 751k | 72.93 | |
| Horizon Therapeutics Pub L SHS | 1.4 | $53M | 568k | 93.64 | |
| Blueprint Medicines (BPMC) | 1.3 | $50M | 563k | 87.96 | |
| Natera (NTRA) | 1.3 | $50M | 436k | 113.53 | |
| Sotera Health (SHC) | 1.3 | $46M | 1.9M | 24.23 | |
| Acceleron Pharma | 1.2 | $45M | 359k | 125.49 | |
| Ideaya Biosciences (IDYA) | 1.2 | $43M | 2.1M | 20.99 | |
| United Therapeutics Corporation (UTHR) | 1.1 | $42M | 236k | 179.41 | |
| Bridgebio Pharma (BBIO) | 1.1 | $41M | 673k | 60.96 | |
| Alphatec Hldgs Com New (ATEC) | 1.1 | $40M | 2.6M | 15.32 | |
| Trillium Therapeutics Com New | 1.1 | $40M | 4.1M | 9.70 | |
| Cyteir Therapeutics | 1.0 | $39M | 1.8M | 21.40 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.0 | $38M | 1.0M | 38.15 | |
| Cardinal Health (CAH) | 1.0 | $37M | 654k | 57.09 | |
| Kadmon Hldgs | 1.0 | $36M | 9.3M | 3.87 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.9 | $34M | 3.4M | 9.85 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $33M | 195k | 169.52 | |
| Insmed Com Par $.01 (INSM) | 0.9 | $33M | 1.2M | 28.46 | |
| Seaspine Holdings | 0.8 | $31M | 1.5M | 20.51 | |
| Lifestance Health Group (LFST) | 0.8 | $31M | 1.1M | 27.86 | |
| Century Therapeutics (IPSC) | 0.8 | $29M | 1.0M | 29.34 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.7 | $26M | 625k | 41.05 | |
| Immunocore Hldgs Ads (IMCR) | 0.6 | $24M | 601k | 39.05 | |
| Adicet Bio (ACET) | 0.6 | $23M | 2.3M | 10.29 | |
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $23M | 940k | 24.39 | |
| Graphite Bio | 0.6 | $23M | 736k | 30.73 | |
| Harpoon Therapeutics | 0.6 | $21M | 1.5M | 13.87 | |
| Uipath Cl A (PATH) | 0.6 | $20M | 300k | 67.93 | |
| Gritstone Oncology Ord (GRTSQ) | 0.5 | $19M | 2.1M | 9.13 | |
| Si-bone (SIBN) | 0.5 | $18M | 575k | 31.47 | |
| Zai Lab Adr (ZLAB) | 0.5 | $18M | 100k | 176.99 | |
| Orchard Therapeutics Ads | 0.4 | $17M | 3.8M | 4.39 | |
| Aldeyra Therapeutics (ALDX) | 0.4 | $16M | 1.5M | 11.33 | |
| Phasebio Pharmaceuticals | 0.4 | $16M | 4.3M | 3.72 | |
| Syneos Health Cl A | 0.4 | $16M | 175k | 89.49 | |
| Sana Biotechnology (SANA) | 0.4 | $15M | 779k | 19.66 | |
| Scynexis Com New (SCYX) | 0.4 | $15M | 2.1M | 7.36 | |
| Alpine Immune Sciences | 0.4 | $14M | 1.5M | 9.00 | |
| Bellus Health Com New | 0.4 | $13M | 4.3M | 3.11 | |
| Ac Immune Sa SHS (ACIU) | 0.3 | $13M | 1.6M | 7.93 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $12M | 560k | 21.73 | |
| Nautilus Biotechnology (NAUT) | 0.3 | $11M | 1.1M | 10.10 | |
| Werewolf Therapeutics (HOWL) | 0.3 | $11M | 650k | 17.44 | |
| Zeta Global Holdings Corp Cl A (ZETA) | 0.3 | $11M | 1.3M | 8.40 | |
| Caremax Com Cl A | 0.3 | $11M | 817k | 12.90 | |
| Prothena Corp SHS (PRTA) | 0.3 | $9.4M | 182k | 51.41 | |
| Cardiff Oncology (CRDF) | 0.3 | $9.3M | 1.4M | 6.65 | |
| Monday SHS (MNDY) | 0.2 | $8.9M | 40k | 223.60 | |
| Iveric Bio | 0.2 | $8.8M | 1.4M | 6.31 | |
| Doximity Cl A (DOCS) | 0.2 | $8.7M | 150k | 58.20 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $8.6M | 104k | 82.82 | |
| Sentinelone Cl A (S) | 0.2 | $8.5M | 200k | 42.50 | |
| Esperion Therapeutics (ESPR) | 0.2 | $8.5M | 400k | 21.15 | |
| Oncosec Medical Incorporated | 0.2 | $7.9M | 2.8M | 2.81 | |
| Instil Bio | 0.2 | $7.7M | 400k | 19.32 | |
| Vir Biotechnology (VIR) | 0.2 | $7.7M | 162k | 47.28 | |
| Pharvaris N V (PHVS) | 0.2 | $7.5M | 400k | 18.63 | |
| Cm Life Sciences Com Cl A | 0.2 | $7.4M | 525k | 14.01 | |
| Monte Rosa Therapeutics (GLUE) | 0.2 | $6.8M | 300k | 22.70 | |
| Denali Therapeutics (DNLI) | 0.2 | $6.8M | 86k | 78.44 | |
| Atai Life Sciences Nv SHS (ATAI) | 0.2 | $6.5M | 351k | 18.50 | |
| Talaris Therapeutics | 0.2 | $6.4M | 436k | 14.69 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.4M | 500k | 10.72 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $5.3M | 500k | 10.53 | |
| Medicus Sciences Acquisition Cl A Shs | 0.1 | $5.0M | 520k | 9.65 | |
| Figs Cl A (FIGS) | 0.1 | $5.0M | 100k | 50.10 | |
| Panacea Acquisition Corp Ii Cl A Shs | 0.1 | $5.0M | 500k | 10.02 | |
| Dynamics Special Purpose Cor Class A Com | 0.1 | $5.0M | 500k | 9.94 | |
| Healthcor Catalio Acqu Corp Cl A Shs | 0.1 | $4.9M | 500k | 9.85 | |
| Celcuity (CELC) | 0.1 | $4.8M | 200k | 24.00 | |
| Confluent Class A Com (CFLT) | 0.1 | $4.8M | 100k | 47.50 | |
| Cm Life Sciences Ii Unit 02/25/2028 | 0.1 | $4.4M | 330k | 13.45 | |
| Walkme Ord Shs | 0.1 | $4.4M | 150k | 29.26 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $4.1M | 400k | 10.35 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.1M | 400k | 10.20 | |
| Lifesci Acquisition Ii Corp | 0.1 | $4.0M | 400k | 10.00 | |
| Bctg Acquisition Corp | 0.1 | $3.4M | 300k | 11.38 | |
| Alpha Teknova (TKNO) | 0.1 | $2.4M | 100k | 23.73 | |
| Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.1 | $2.0M | 200k | 10.12 | |
| Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.1 | $2.0M | 200k | 10.11 | |
| Social Cap Suvretta Hld Crpi Class A Ord Shs | 0.1 | $2.0M | 200k | 10.11 | |
| Social Cap Suvretta Hlds Cp Class A Ord Shs | 0.1 | $2.0M | 200k | 10.10 | |
| Flywire Corporation Com Vtg (FLYW) | 0.0 | $1.8M | 50k | 36.74 | |
| Clovis Oncology | 0.0 | $1.6M | 272k | 5.80 | |
| Singular Genomics Systems In | 0.0 | $1.4M | 50k | 27.48 | |
| Neuropace (NPCE) | 0.0 | $952k | 40k | 23.80 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $260k | 100k | 2.60 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $58k | 58k | 1.00 |
